Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth
Clinical trial NCT00685854 · COMPLETED
Trial details
- NCT number
- NCT00685854
- Sponsor
- National Eye Institute (NEI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-21
- Primary completion
- 2011-03-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.